Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Dental PlaqueSide Effects
Interventions
DRUG

Placebo: PCB

Participants were asked to rinse every 12 hours, with 15 ml for 30 seconds, and after spitting to refrain from rinsing their mouths with water and from eating or drinking for at least 60 minutes.

DRUG

0.12%NF

Participants were asked to rinse every 12 hours, with 15 ml for 30 seconds, and after spitting to refrain from rinsing their mouths with water and from eating or drinking for at least 60 minutes.

DRUG

0.03%NF

Participants were asked to rinse every 12 hours, with 15 ml for 30 seconds, and after spitting to refrain from rinsing their mouths with water and from eating or drinking for at least 60 minutes.

DRUG

PAT

Patients were asked to rinse every 12 hours, and after spitting to refrain from rinsing their mouths with water and from eating or drinking for at least 60 minutes.

Trial Locations (1)

08195

UIC dental office, Hospital General de Catalunya, Sant Cugat del Vallès

All Listed Sponsors
collaborator

Dentaid SL

INDUSTRY

lead

Universitat Internacional de Catalunya

OTHER

NCT02194023 - Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%. | Biotech Hunter | Biotech Hunter